Highly Cited Authors

The Scientist's new format represents a turning point in the long evolution of my involvement in the field of scientific communication. Although a major part of my work has been devoted to improving scientific information retrieval and dissemination, I have been identified increasingly with the emergent fields of scientometrics and research evaluation. Citation data have become a normal—though sometimes controversial—part of the evaluation of institutions and individuals. One can onl

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I founded the Institute for Scientific Information (www.isinet.com) in 1954 but did not begin publishing the Science Citation Index regularly until 1964. The Scientist appeared more than two decades later, in 1986, and soon went online as one of the first full-text electronic Web sites. A few years later The Scientist was spun off when I sold my shares in ISI. I published it until December 2001, when it became a joint venture with Vitek Tracz of Current Science Inc. I have remained chairman emeritus of ISI, now wholly owned by the Thomson Corp., even though I am no longer a shareholder. But I revel in describing innovative ISI products.

ISI has now made a quantum leap forward in providing free access to a new database called ISI Highly Cited.com. This database provides detailed publication, citation, and biographical data on several thousand authors in categories such as molecular biology, chemistry, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies